Debt-to-equity of Applied Therapeutics, Inc. from 30 Sep 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Applied Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2019 to 30 Sep 2025.
  • Applied Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 95%, a 61% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Applied Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 95% -148% -61% 30 Sep 2025
Q2 2025 146% -94% -39% 30 Jun 2025
Q1 2025 120% -628% -84% 31 Mar 2025
Q4 2024 133% +708% 31 Dec 2024
Q3 2024 243% +1364% 30 Sep 2024
Q2 2024 240% -2853% -92% 30 Jun 2024
Q1 2024 748% +275% +58% 31 Mar 2024
Q4 2023 -575% -767% -399% 31 Dec 2023
Q3 2023 -1122% -1229% -1148% 30 Sep 2023
Q2 2023 3093% +3030% +4887% 30 Jun 2023
Q1 2023 474% +439% +1248% 31 Mar 2023
Q4 2022 192% +166% +629% 31 Dec 2022
Q3 2022 107% +83% +346% 30 Sep 2022
Q2 2022 62% +41% +198% 30 Jun 2022
Q1 2022 35% +16% +84% 31 Mar 2022
Q4 2021 26% +10% +66% 31 Dec 2021
Q3 2021 24% +7.8% +49% 30 Sep 2021
Q2 2021 21% +5.7% +38% 30 Jun 2021
Q1 2021 19% +4% +26% 31 Mar 2021
Q4 2020 16% -31% -66% 31 Dec 2020
Q3 2020 16% -87% -84% 30 Sep 2020
Q2 2020 15% 30 Jun 2020
Q1 2020 15% 31 Mar 2020
Q4 2019 47% 31 Dec 2019
Q3 2019 103% 30 Sep 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.